Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-05T14:41:37.385Z Has data issue: false hasContentIssue false

81 - Mannitol

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Osmitrol

Generic?

• Yes

Class

• Osmotic diuretic

Commonly Prescribed for

(FDA approved in bold)

Reduction of elevated intracranial pressure (ICP)

Reduction of elevated intraocular pressure

Diuresis (prophylaxis in acute renal failure)

Increased excretion of urinary toxins

Urological irrigation

How the Drug Works

• Mannitol induces diuresis by elevating the osmolarity of the glomerular filtrate, which decreases tubular reabsorption of water

How Long Until It Works

• 15 minutes

If It Works

• Assess effectiveness and need for continued use. Usually used as a short-term measure before more definitive treatment

If It Doesn't Work

• Usually mannitol is a temporary measure for acute increases in ICP before more definitive treatment

Best Augmenting Combos for Partial Response or Treatment-Resistance

• Treatment of increased ICP depends on the etiology

• Causes of increased ICP due to general swelling include liver failure, hypertensive encephalopathy, and hypercarbia. Intervention should consist of treating the underlying medical problem

• In some cases, meningitis can cause increased production of CSF or obstruction of CSF flow

• Increased ICP due to mass effect from stroke (ischemic or hemorrhagic) may require neurosurgical intervention such as an intraventricular catheter, craniotomy, or craniectomy

• Permitting hypertension may increase perfusion and reduce swelling, but calcium channel blockers may also be useful (especially in subarachnoid hemorrhage)

• Analgesia and sedation may be useful

• Hyperventilation, hypothermia, and barbiturate coma are occasionally used, usually in refractory cases

• Hypertonic saline is an alternative to mannitol for acutely increased ICP

• Corticosteroids are often used to reduce vasogenic edema, i.e., brain tumors

Tests

• Carefully monitor serum sodium, potassium, BUN, and urine output during therapy

ADVERSE EFFECTS (AEs)

How the Drug Causes AEs

• Most are related to changes in electrolytes and diuresis

Notable AEs

• Pulmonary edema, hypo- or hypertension, tachycardia

• Headache, thirst, nausea, diarrhea, blurred vision, rhinitis, chills, fever

Life-Threatening or Dangerous AEs

• Severe hypernatremia or renal failure

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 302 - 304
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Mannitol
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.082
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Mannitol
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.082
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Mannitol
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.082
Available formats
×